Waldenstrom Macroglobulinemia Recurrence with Bing–Neel Syndrome Presentation
Abstract
:1. Introduction
2. Detailed Case Description
3. Discussion
4. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Ly, K.I.; Fintelmann, F.; Forghani, R.; Schaefer, P.W.; Hochberg, E.P.; Hochberg, F.H. Novel diagnostic approaches in Bing-Neel syndrome. Clin. Lymphoma Myeloma Leuk. 2011, 11, 180–183. [Google Scholar] [CrossRef] [PubMed]
- Fitsiori, A.; Fornecker, L.M.; Simon, L.; Karentzos, A.; Galanaud, D.; Outteryck, O.; Vermersch, P.; Pruvo, J.-P.; Gerardin, E.; Lebrun-Frenay, C.; et al. Imaging spectrum of Bing–Neel syndrome: How can a radiologist recognise this rare neurological complication of Waldenström’s macroglobulinemia? Eur. Radiol. 2019, 29, 102–114. [Google Scholar] [CrossRef] [PubMed]
- Levine, T.; Pestronk, A.; Florence, J.; Al-Lozi, M.T.; Lopate, G.; Miller, T.; Ramneantu, I.; Waheed, W.; Stambuk, M.; Stone, M.J.; et al. Peripheral neuropathies in Waldenström’s macroglobulinaemia. J. Neurol. Neurosurg. Psychiatry 2006, 77, 224–228. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Baehring, J.M.; Hochberg, E.P.; Raje, N.; Ulrickson, M.; Hochberg, F.H. Neurological manifestations of Waldenstrom macroglobulinemia. Nat. Clin. Pract. Neurol. 2008, 4, 547–556. [Google Scholar] [CrossRef]
- Kotsos, D.; Chatzileontiadou, S.; Apsemidou, A.; Xanthopoulou, A.; Rapi, A.; Frouzaki, C.; Hatjiharissi, E. Bing-Neel Syndrome: Real-Life Experience in Personalized Diagnostic Approach and Treatment. Front. Oncol. 2022, 12, 891052. [Google Scholar] [CrossRef] [PubMed]
- Drozd-Sokołowska, J.; Waszczuk-Gajda, A.; Witkowska, M.; Sienkiewicz, E.; Kopińska, A.; Kołkowska-Leśniak, A.; Barankiewicz, J.; Długosz-Danecka, M.; Smolewski, P.; Helbig, G.; et al. Bing-Neel Syndrome, a Rare Presentation of Waldenström Macroglobulinemia—A Multicenter Report by the Polish Lymphoma Research Group. J. Clin. Med. 2022, 11, 4447. [Google Scholar] [CrossRef] [PubMed]
- Varettoni, M.; Defrancesco, I.; Diamanti, L.; Marchioni, E.; Farina, L.M.; Pichiecchio, A. Bing-Neel Syndrome: Illustrative Cases and Comprehensive Review of the Literature. Mediterr. J. Hematol. Infect. Dis. 2017, 9, e2017061. [Google Scholar] [CrossRef] [PubMed]
- Simon, L.; Fitsiori, A.; Lemal, R.; Dupuis, J.; Carpentier, B.; Boudin, L.; Corby, A.; Aurran-Schleinitz, T.; Gastaud, L.; Talbot, A.; et al. Bing-Neel syndrome, a rare complication of Waldenström macroglobulinemia: Analysis of 44 cases and review of the literature. A study on behalf of the French Innovative Leukemia Organization (FILO). Haematologica 2015, 100, 1587–1594. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Kulkarni, T.; Treon, S.P.; Manning, R.; Xu, L.; Rinne, M.; Lee, E.Q.; Ghobrial, I.M.; Norden, A.; Kluk, M.J.; Nayak, L. Clinical Characteristics and Treatment Outcome Of CNS Involvement (Bing-Neel Syndrome) in Waldenstrom’s Macroglobulinemia. Blood 2013, 122, 5090. [Google Scholar] [CrossRef]
- Kim, H.J.; Suh, S.I.; Kim, J.H.; Kim, B.J. Brain magnetic resolution imaging to diagnose bing-neel syndrome. J. Korean Neurosurg. Soc. 2009, 46, 588–591. [Google Scholar] [CrossRef] [PubMed]
- Minnema, M.C.; Kimby, E.; D’Sa, S.; Fornecker, L.M.; Poulain, S.; Snijders, T.J.; Kastritis, E.; Kremer, S.; Fitsiori, A.; Simon, L.; et al. Guideline for the diagnosis, treatment and response criteria for Bing-Neel syndrome. Haematologica 2017, 102, 43–51. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Wong, E.Y.; D’Sa, S.; Minnema, M.C.; Castillo, J.J.; Talaulikar, D. Bing–Neel Syndrome: Update on Diagnosis and Treatment. Hemato 2022, 3, 758–770. [Google Scholar] [CrossRef]
- Castillo, J.J.; Treon, S.P. How we manage Bing–Neel syndrome. Br. J. Haematol. 2019, 187, 277–285. [Google Scholar] [CrossRef]
- Castillo, J.J.; Itchaki, G.; Paludo, J.; Varettoni, M.; Buske, C.; Eyre, T.A.; Chavez, J.C.; Shain, K.H.; Issa, S.; Palomba, M.L.; et al. Ibrutinib for the treatment of Bing-Neel syndrome: A multicenter study. Blood 2019, 133, 299–305. [Google Scholar] [CrossRef] [PubMed]
- Zhang, Y.; Ye, J.; Chen, H.; Zhou, D.; Ji, C. Efficacy and Safety of BTKis in Central Nervous System Lymphoma: A Systematic Review and Meta-Analysis. Cancers 2024, 16, 860. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Capasso, R.; Buonincontro, M.; Caranci, F.; Pinto, A. Waldenstrom Macroglobulinemia Recurrence with Bing–Neel Syndrome Presentation. Reports 2024, 7, 34. https://doi.org/10.3390/reports7020034
Capasso R, Buonincontro M, Caranci F, Pinto A. Waldenstrom Macroglobulinemia Recurrence with Bing–Neel Syndrome Presentation. Reports. 2024; 7(2):34. https://doi.org/10.3390/reports7020034
Chicago/Turabian StyleCapasso, Raffaella, Miriam Buonincontro, Ferdinando Caranci, and Antonio Pinto. 2024. "Waldenstrom Macroglobulinemia Recurrence with Bing–Neel Syndrome Presentation" Reports 7, no. 2: 34. https://doi.org/10.3390/reports7020034